Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica

Medicine & Life Sciences

• Polymyalgia Rheumatica 100%
• Adrenal Cortex Hormones 56%
• Anti-Inflammatory Agents 51%
• Giant Cell Arteritis 22%
• Pharmaceutical Preparations 18%
• Therapeutics 11%
• Femoral Neck Fractures 10%
• Rheumatologists 10%
• Hip Fractures 9%
• Prednisone 8%
• Duration of Therapy 8%
• Diabetes Mellitus 6%
• Epidemiology 6%
• Population 6%
• Referral and Consultation 6%
• Regression Analysis 5%
• Demography 5%
• Databases 5%
• Morbidity 5%
• Drug Therapy 5%
• Incidence 4%